• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加入欧盟10年后罗马尼亚女性乳腺癌死亡率与欧盟的差距:乳腺癌筛查是罗马尼亚的行动重点吗?(统计数据综述)

Breast cancer mortality gaps in Romanian women compared to the EU after 10 years of accession: Is breast cancer screening a priority for action in Romania? (Review of the Statistics).

作者信息

Furtunescu Florentina, Bohiltea Roxana Elena, Voinea Silviu, Georgescu Tiberiu Augustin, Munteanu Octavian, Neacsu Adrian, Pop Corina Silvia

机构信息

Department of Public Health and Management, Faculty of Medicine, 'Carol Davila' University of Medicine and Pharmacy, 050463 Bucharest, Romania.

Department of Obstetrics and Gynecology, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.

出版信息

Exp Ther Med. 2021 Mar;21(3):268. doi: 10.3892/etm.2021.9699. Epub 2021 Jan 25.

DOI:10.3892/etm.2021.9699
PMID:33603875
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7851664/
Abstract

Breast cancer remains the most common cause of morbidity and mortality by cancer in females worldwide, even though it is largely preventable through population screening. Despite notable progress in the last years in the EU, breast cancer screening programs still maintain wide variations among countries and socio-economic groups. This statistical review aimed to investigate the breast cancer-related health gaps in Romanian women compared to the average EU female population after 10 years of accession (2007-2016). We evaluated breast cancer-related deaths, age-standardized mortality rates and contribution of breast cancer to life expectancy. Trends and percentage changes were compared between Romania and EU-27 for breast cancer, all cancer and all causes of mortality. We found a higher increase of breast cancer deaths in Romania, an increasing trend of mortality (opposite to EU) and a contribution to life expectancy at birth that increased gradually from 0.45 to 0 48 years. All these health gaps compared to EU are aggravated by the fact that no population screening for breast cancer is organized in the country. The opportunities for organizing such a program are consistent, but they should be increased in the future, in order to control the health gap between Romania and EU.

摘要

乳腺癌仍然是全球女性癌症发病和死亡的最常见原因,尽管通过人群筛查在很大程度上是可以预防的。尽管欧盟在过去几年取得了显著进展,但乳腺癌筛查项目在各国和社会经济群体之间仍存在很大差异。本统计综述旨在调查罗马尼亚女性在加入欧盟10年后(2007 - 2016年)与欧盟女性平均人口相比在乳腺癌相关健康方面的差距。我们评估了乳腺癌相关死亡、年龄标准化死亡率以及乳腺癌对预期寿命的影响。比较了罗马尼亚与欧盟27国在乳腺癌、所有癌症以及所有死亡原因方面的趋势和百分比变化。我们发现罗马尼亚乳腺癌死亡人数的增长幅度更大,死亡率呈上升趋势(与欧盟相反),并且对出生时预期寿命的影响从0.45岁逐渐增加到0.48岁。与欧盟相比,该国未组织乳腺癌人群筛查这一事实加剧了所有这些健康差距。开展此类项目的机会是存在的,但未来应增加这些机会,以缩小罗马尼亚与欧盟之间的健康差距。

相似文献

1
Breast cancer mortality gaps in Romanian women compared to the EU after 10 years of accession: Is breast cancer screening a priority for action in Romania? (Review of the Statistics).加入欧盟10年后罗马尼亚女性乳腺癌死亡率与欧盟的差距:乳腺癌筛查是罗马尼亚的行动重点吗?(统计数据综述)
Exp Ther Med. 2021 Mar;21(3):268. doi: 10.3892/etm.2021.9699. Epub 2021 Jan 25.
2
CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.美国疾病控制与预防中心国家健康报告:2005 - 2013年美国发病和死亡的主要原因以及相关行为风险和保护因素
MMWR Suppl. 2014 Oct 31;63(4):3-27.
3
Cervical Cancer Mortality in Romania: Trends, Regional and Rural-Urban Inequalities, and Policy Implications.罗马尼亚宫颈癌死亡率:趋势、地区和城乡不平等及其政策意义。
Medicina (Kaunas). 2021 Dec 23;58(1):18. doi: 10.3390/medicina58010018.
4
Changing life expectancy in Romania after the transition.转型后罗马尼亚的预期寿命变化
J Epidemiol Community Health. 2002 Jun;56(6):444-9. doi: 10.1136/jech.56.6.444.
5
BREAST CANCER SCREENING IN ROMANIA: CHALLENGES AND OPPORTUNITIES FOR EARLY DETECTION.罗马尼亚的乳腺癌筛查:早期检测面临的挑战与机遇
Acta Endocrinol (Buchar). 2024 Jan-Mar;20(1):45-50. doi: 10.4183/aeb.2024.45. Epub 2024 Oct 3.
6
A Novel Approach to Modeling and Forecasting Cancer Incidence and Mortality Rates through Web Queries and Automated Forecasting Algorithms: Evidence from Romania.一种通过网络查询和自动预测算法对癌症发病率和死亡率进行建模与预测的新方法:来自罗马尼亚的证据。
Biology (Basel). 2022 Jun 3;11(6):857. doi: 10.3390/biology11060857.
7
Mortality trend in a rapidly developing economy in Taiwan. Part II: Life expectancy and "potential years of life lost".台湾快速发展经济体中的死亡率趋势。第二部分:预期寿命与“潜在寿命损失年数”
Asia Pac J Public Health. 1991;5(1):49-53. doi: 10.1177/101053959100500111.
8
Trends in cervical cancer incidence and mortality in the Baltic countries, Bulgaria and Romania.波罗的海国家、保加利亚和罗马尼亚的宫颈癌发病率和死亡率趋势。
Int J Cancer. 2011 Apr 15;128(8):1899-907. doi: 10.1002/ijc.25525.
9
Breast cancer mortality trends in Europe among women in perimenopausal and postmenopausal age (45+).欧洲围绝经期和绝经后年龄(45岁及以上)女性的乳腺癌死亡率趋势。
Arch Med Sci. 2019 Jul 11;16(1):146-156. doi: 10.5114/aoms.2019.85198. eCollection 2020.
10
Mortality trends in chronic obstructive pulmonary disease in Europe, 1994-2010: a joinpoint regression analysis.1994-2010 年欧洲慢性阻塞性肺疾病死亡率趋势:一个联合回归分析。
Lancet Respir Med. 2014 Jan;2(1):54-62. doi: 10.1016/S2213-2600(13)70232-7. Epub 2013 Dec 6.

引用本文的文献

1
Therapeutic Patterns and Surgical Decision-Making in Breast Cancer: A Retrospective Regional Cohort Study in Romania.乳腺癌的治疗模式与手术决策:罗马尼亚的一项回顾性区域队列研究
Clin Pract. 2025 Aug 5;15(8):145. doi: 10.3390/clinpract15080145.
2
Breast cancer mortality in Romania: trends, regional and rural-urban inequalities, and policy implications.罗马尼亚的乳腺癌死亡率:趋势、地区及城乡不平等现象与政策影响
BMC Cancer. 2025 Jul 1;25(1):1038. doi: 10.1186/s12885-025-14090-3.
3
Assessing personal and health system barriers to breast cancer early diagnosis practices for women over 20 years old in Cluj-Napoca, Romania.评估罗马尼亚克鲁日-纳波卡市20岁以上女性乳腺癌早期诊断实践中的个人和卫生系统障碍。
Med Pharm Rep. 2025 Jan;98(1):118-124. doi: 10.15386/mpr-2694. Epub 2025 Jan 31.
4
Gynecological Insights into Lynch Syndrome-A Comprehensive Review of Cancer Screening and Prevention.林奇综合征的妇科见解——癌症筛查与预防综述
Medicina (Kaunas). 2024 Dec 6;60(12):2013. doi: 10.3390/medicina60122013.
5
Real-World Efficacy and Adherence to Palbociclib in HR-Positive, HER2-Negative Advanced Breast Cancer: Insights from a Romanian Cohort.真实世界中哌柏西利在激素受体阳性、人表皮生长因子受体2阴性晚期乳腺癌中的疗效与依从性:来自罗马尼亚队列的见解
Cancers (Basel). 2024 Dec 13;16(24):4161. doi: 10.3390/cancers16244161.
6
Breast Cancer and Its Impact on Individual Personality Through a Dimensional Perspective: A Literature Review.从维度视角看乳腺癌及其对个体人格的影响:文献综述
Cureus. 2024 Jul 11;16(7):e64348. doi: 10.7759/cureus.64348. eCollection 2024 Jul.
7
Breast Cancer Screening and Prophylactic Mastectomy for High-Risk Women in Romania.罗马尼亚高危女性的乳腺癌筛查与预防性乳房切除术
Medicina (Kaunas). 2024 Mar 30;60(4):570. doi: 10.3390/medicina60040570.
8
Social Media Campaigns: A Game Changer for the Prevention of Breast Cancer in Romania.社交媒体活动:罗马尼亚预防乳腺癌的变革力量。
Healthcare (Basel). 2024 Apr 22;12(8):865. doi: 10.3390/healthcare12080865.
9
Digging in real-word electronic database for assessing CDK 4/6 inhibitors adherence in breast cancer patients from Romania.挖掘真实世界电子数据库以评估罗马尼亚乳腺癌患者对CDK 4/6抑制剂的依从性。
Front Pharmacol. 2024 Feb 23;15:1345482. doi: 10.3389/fphar.2024.1345482. eCollection 2024.
10
Inequities in Screening and HPV Vaccination Programs and Their Impact on Cervical Cancer Statistics in Romania.罗马尼亚筛查与HPV疫苗接种计划中的不平等现象及其对宫颈癌统计数据的影响。
Diagnostics (Basel). 2023 Aug 28;13(17):2776. doi: 10.3390/diagnostics13172776.

本文引用的文献

1
Current Guidelines and Gaps in Breast Cancer Screening.乳腺癌筛查的现行指南与差距
J Am Coll Radiol. 2020 Oct;17(10):1269-1275. doi: 10.1016/j.jacr.2020.05.002. Epub 2020 May 28.
2
National Breast Screening Programs across Europe.欧洲各地的国家乳腺癌筛查项目。
Breast Care (Basel). 2019 Dec;14(6):354-358. doi: 10.1159/000503715. Epub 2019 Oct 25.
3
Evidence for reducing cancer-specific mortality due to screening for breast cancer in Europe: A systematic review.欧洲乳腺癌筛查降低癌症特异性死亡率的证据:系统评价。
Eur J Cancer. 2020 Mar;127:191-206. doi: 10.1016/j.ejca.2019.12.010. Epub 2020 Jan 10.
4
Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017.全球 195 个国家和地区 1990 年至 2017 年乳腺癌发病及归因危险因素负担:2017 年全球疾病负担研究结果。
J Hematol Oncol. 2019 Dec 21;12(1):140. doi: 10.1186/s13045-019-0828-0.
5
Venous thromboembolism in cancer patients: Still looking for answers.癌症患者的静脉血栓栓塞:仍在探寻答案。
Exp Ther Med. 2019 Dec;18(6):5026-5032. doi: 10.3892/etm.2019.8019. Epub 2019 Sep 18.
6
Modern interdisciplinary monitoring of cervical cancer risk.现代宫颈癌风险的多学科监测
Rom J Morphol Embryol. 2019;60(2):469-478.
7
Incidence and death in 29 cancer groups in 2017 and trend analysis from 1990 to 2017 from the Global Burden of Disease Study.2017 年 29 种癌症的发病率和死亡率以及 1990 年至 2017 年的趋势分析,来自全球疾病负担研究。
J Hematol Oncol. 2019 Sep 12;12(1):96. doi: 10.1186/s13045-019-0783-9.
8
Global Trend of Breast Cancer Mortality Rate: A 25-Year Study.全球乳腺癌死亡率趋势:一项为期25年的研究。
Asian Pac J Cancer Prev. 2019 Jul 1;20(7):2015-2020. doi: 10.31557/APJCP.2019.20.7.2015.
9
The breast cancer paradox: A systematic review of the association between area-level deprivation and breast cancer screening uptake in Europe.乳腺癌悖论:欧洲地区层面贫困与乳腺癌筛查接受情况之间关联的系统评价
Cancer Epidemiol. 2019 Jun;60:77-85. doi: 10.1016/j.canep.2019.03.008. Epub 2019 Mar 28.
10
The Situation of Cervical Cancers in the Context of Female Genital Cancer Clustering and Burden of Disease in Arad County, Romania.罗马尼亚阿拉德县女性生殖系统癌症聚集及疾病负担背景下的宫颈癌情况
J Clin Med. 2019 Jan 15;8(1):96. doi: 10.3390/jcm8010096.